Brief: Casi Pharmaceuticals Announces Pricing Of $32.5 Mln Public Offering Of Common Stock
24/03/2021 12:33
March 24 (Reuters) - CASI Pharmaceuticals Inc CASI.O :
* CASI PHARMACEUTICALS ANNOUNCES PRICING OF $32,500,000
PUBLIC
OFFERING OF COMMON STOCK
* SAYS PUBLIC OFFERING OF 15.9 MILLION COMMON SHARES PRICED
AT
$2.05PER SHARE
Source text for Eikon: ID:nPn37G11Ra
Further company coverage: CASI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CASI Pharmaceuticals
See all newsBrief: Casi Pharmaceuticals Reports The Receipt Of Drug Registration Certificate For Thiotepa In China
CASI Pharmaceuticals Q3 revenue drops 60%, net loss widens
Brief: CASI Pharmaceuticals Inc Reports The Expiration Of Import Drug Registration License For Folotyn® In China
Casi Pharmaceuticals Inc Expected To Post A Loss Of 47 Cents A Share: Earnings Preview
Casi Pharmaceuticals Inc Reports Results For The Quarter Ended March 31: Earnings Summary